Sinocelltech Group
Latest round
- Series B
Last raised
- Feb 2019
Total raised
- Undisclosed
Investors
- 3
About Sinocelltech Group
Established in 2007 and based in Beijing, China, Sino Biological Inc. operates as a contract research organization (CRO) service provider that focuses on biotechnology. The company has 330 employees and 33% of the core research team has master's degree. The founder, Dr. Liangzhi Xie has undertaken a number of national "863" program, and the national "new drug creation" major special projects. In April 2016, the company's product, SCT400, entered the clinical phase III. Sino Biological provides the R&D, production, sales and technology of biological reagent and pre-clinical scale production service for pharmaceutical company or biotech company. The product of the company includes recombinant protein, antibody, gene and culture medium, such as IL-1 beta primes innate immunity, CD155 and its receptors and common humancoronavirus(HCoV) antigens. The CRO service of the company includes recombinant protein and antibody development and biological analysis and detection. Sino Biological adopts quality control system, such as molecular level testing, basic physical and chemical testing, multiple immunological testing.
Who invested in Sinocelltech Group
3 investors across 1 round
See all investors in Sinocelltech Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 28, 2019
Amount
Undisclosed
Investors
Questions about Sinocelltech Group
Who invested in Sinocelltech Group?
Sinocelltech Group has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sinocelltech Group raised?
Sinocelltech Group has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sinocelltech Group last raise money?
Sinocelltech Group's most recent round on record is a Series B, in Feb 2019.
What does Sinocelltech Group do?
Established in 2007 and based in Beijing, China, Sino Biological Inc.
Where is Sinocelltech Group headquartered?
Sinocelltech Group is headquartered in Beijing, China.
Which VCs invest in companies like Sinocelltech Group?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sinocelltech Group's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sinocelltech Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.